SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-506570"
 

Search: onr:"swepub:oai:DiVA.org:uu-506570" > Characterization of...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Nilsson, ChristerKarolinska Institute,Karolinska Inst, Sweden (author)

Characterization of therapy-related acute myeloid leukemia : increasing incidence and prognostic implications

  • Article/chapterEnglish2023

Publisher, publication year, extent ...

  • 2022-08-25
  • Ferrata Storti Foundation,2023
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-506570
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-506570URI
  • https://doi.org/10.3324/haematol.2022.281233DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:152805242URI
  • https://lup.lub.lu.se/record/c3dbf486-6b87-4bc2-951f-ff44d2604805URI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-195344URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies|Swedish Cancer Foundation; Swedish Research Council; Stockholm County Council
  • Studies of therapy-related AML (t-AML) are usually performed in selected cohorts and reliable incidence rates are lacking. In this study, we characterized, defined the incidence over time and studied prognostic implications in all t-AML patients diagnosed in Sweden between 1997 and 2015. Data were retrieved from nationwide population-based registries. In total, 6,779 AML patients were included in the study, of whom 686 (10%) had t-AML. The median age for t-AML was 71 years and 392 (57%) patients were females. During the study period, the incidence of t-AML almost doubled with a yearly increase in t-AML of 4.5% (95% confidence interval: 2.8%-6.2%), which contributed significantly to the general increase in AML incidence over the study period. t-AML solidly constituted over 10% of all AML cases during the later period of the study. Primary diagnoses with the largest increase in incidence and decrease in mortality rate during the study period (i.e., breast and prostate cancer) contributed significantly to the increased incidence of t-AML. In multivariable analysis, t-AML was associated with poorer outcome in cytogenetically intermediate-and adverse-risk cases but t-AML had no significant impact on outcome in favorable-risk AML, including core binding leukemias, acute promyelocytic leukemia and AML with mutated NPM1 without FLT3-ITD. We conclude that there is a strong increase in incidence in t-AML over time and that t-AML constitutes a successively larger proportion of the AML cases. Furthermore, we conclude that t-AML confers a poor prognosis in cytogenetically intermediate-and adverse-risk, but not in favorable-risk AML.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Linde, FredrikaUppsala University,Uppsala universitet,Institutionen för medicinska vetenskaper,Uppsala Univ, Sweden (author)
  • Hulegardh, ErikSahlgrens Univ Hosp, Dept Hematol, Gothenburg, Sweden.,Sahlgrenska University Hospital (author)
  • Garelius, HegeSahlgrens Univ Hosp, Dept Hematol, Gothenburg, Sweden.,Sahlgrenska University Hospital (author)
  • Lazarevic, VladimirLund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,Leukemi, genetik, epidemiologi,Forskargrupper vid Lunds universitet,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine,Leukemia, Genetics, Epidemiology,Lund University Research Groups,Skåne University Hospital,Skane Univ Hosp, Sweden; Lund Univ, Sweden(Swepub:lu)med-lzv (author)
  • Antunovic, PetarLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Hematologiska kliniken US(Swepub:liu)petan27 (author)
  • Cammenga, JörgLinköpings universitet,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Hematologiska kliniken US(Swepub:liu)jorca02 (author)
  • Deneberg, StefanKarolinska Institute,Karolinska Institutet,Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden. (author)
  • Eriksson, Anna,1977-Uppsala universitet,Hematologi,Uppsala Univ, Sweden(Swepub:uu)anner268 (author)
  • Jadersten, MartinKarolinska Institute,Karolinska Institutet,Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden. (author)
  • Bjorkvall, Cecilia KampeNorrland Univ Hosp, Dept Hematol, Umeå, Sweden.,Norrland University Hospital (author)
  • Mollgard, LarsSahlgrens Univ Hosp, Dept Hematol, Gothenburg, Sweden.,Sahlgrenska University Hospital (author)
  • Wennstrom, LovisaSahlgrens Univ Hosp, Dept Hematol, Gothenburg, Sweden.,Sahlgrenska University Hospital (author)
  • Olander, EmmaSundsvall Hosp, Dept Hematol, Sundsvall, Sweden.,Sundsvall Hospital (author)
  • Höglund, MartinUppsala universitet,Hematologi,Uppsala Univ, Sweden(Swepub:uu)martinhl (author)
  • Juliusson, GunnarLund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Leukemi, genetik, epidemiologi,Forskargrupper vid Lunds universitet,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Leukemia, Genetics, Epidemiology,Lund University Research Groups,Skåne University Hospital,Skane Univ Hosp, Sweden; Lund Univ, Sweden(Swepub:lu)stem-gju (author)
  • Lehmann, SörenUppsala University,Karolinska Institute,Uppsala universitet,Hematologi,Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden.,Karolinska Inst, Sweden; Uppsala Univ, Sweden(Swepub:uu)sorle534 (author)
  • Karolinska InstituteKarolinska Inst, Sweden (creator_code:org_t)

Related titles

  • In:Haematologica: Ferrata Storti Foundation108:4, s. 1015-10250390-60781592-8721

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view